Hyaluronan expression in differentiated thyroid carcinoma

被引:25
作者
Böhm, J
Niskanen, L
Tammi, R
Tammi, M
Eskelinen, M
Pirinen, R
Hollmen, S
Alhava, E
Kosma, VM
机构
[1] Univ Kuopio, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Med & Clin Nutr, SF-70210 Kuopio, Finland
[3] Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Surg, SF-70210 Kuopio, Finland
[5] Satakunta Cent Hosp, Dept Pathol, Pori, Finland
关键词
differentiated thyroid carcinoma; hyaluronan; mortality; prognosis;
D O I
10.1002/path.1032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extracellular polysaccharide hyaluronan (HA) controls cell migration, differentiation, and proliferation, and is supposed to contribute to the spreading of several human cancers. Little is known about the role of HA in the development and progression of differentiated thyroid carcinoma (DTC). The expression and prognostic value of HA were therefore evaluated in 20.1 consecutive patients with DTC. A biotinylated affinity probe specific for HA was applied to paraffin-embedded tumour samples to assay the expression of HA in carcinoma cells and in intra/peritumoural stroma. In a majority of the samples, a high percentage ( greater than or equal to90%) of normal thyroid follicle epithelial cells were HA-positive. This high percentage was also found in 80 (47%) papillary carcinomas, but only in seven (21%) follicular carcinomas (p=0.004). Age (>60 years) of the patients was significantly associated with a low percentage of HA-positive cancer cells (p=0.013). Cancer cell-associated HA correlated significantly with the percentage of cells expressing total CD44 and its isoforms containing exons v3 and v6 (r =0.223-0.289, p < 0.001 for all). The tumour stroma was always positive for HA. Stromal staining intensity did not differ markedly between papillary and follicular carcinomas. A strong stromal HA staining intensity was related to distant metastases (p=0.044), high pTNM stage (p=0.024), old age (>60 years) (p=0.043), and cancer-related mortality (p=0.001). In a log-rant: univariate survival analysis, strong stromal HA staining intensity was related to DTC mortality (p=0.0007). Cancer cell-associated HA expression did not significantly correlate with patient survival. In Cox's multivariate survival analysis, age (>60 years, p=0.0164), gender (p=0.0251), and pTNM stage (p=0.0121) were significant independent prognostic factors for DTC-related death. These results suggest that strong stromal HA staining intensity is related to progression and unfavourable outcome in DTC patients, while the clinical factors retrain more powerful in predicting DTC-related death. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:180 / 185
页数:6
相关论文
共 31 条
[1]  
Anttila MA, 2000, CANCER RES, V60, P150
[2]   Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival [J].
Auvinen, P ;
Tammi, R ;
Parkkinen, J ;
Tammi, M ;
Ågren, U ;
Johansson, R ;
Hirvikoski, P ;
Eskelinen, M ;
Kosma, VM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :529-536
[3]  
BAZIL V, 1994, J IMMUNOL, V152, P1314
[4]  
Böhm JP, 2000, J PATHOL, V192, P321
[5]   DISTANT METASTASES IN PAPILLARY THYROID-CARCINOMA - 100 CASES OBSERVED AT ONE INSTITUTION DURING 5 DECADES [J].
DINNEEN, SF ;
VALIMAKI, MJ ;
BERGSTRALH, EJ ;
GOELLNER, JR ;
GORMAN, CA ;
HAY, ID .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2041-2045
[6]  
EGGO MC, 1995, J CLIN ENDOCR METAB, V80, P1006, DOI 10.1210/jc.80.3.1006
[7]   Hyaluronan: Its nature, distribution, functions and turnover [J].
Fraser, JRE ;
Laurent, TC ;
Laurent, UBG .
JOURNAL OF INTERNAL MEDICINE, 1997, 242 (01) :27-33
[8]  
Gao AC, 1998, CANCER RES, V58, P2350
[9]   FOLLICULAR THYROID-CANCER [J].
GREBE, SKG ;
HAY, ID .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (04) :761-+
[10]   Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability [J].
Hasan, NM ;
Adams, GE ;
Joiner, MC ;
Marshall, JF ;
Hart, IR .
BRITISH JOURNAL OF CANCER, 1998, 77 (11) :1799-1805